Cookies on this site

David Bonsall

Group Leader and PI

  • Sequencing and Sequencing Methods
  • BDI - Pathogen Dynamics - Wellcome Centre for Human Genetics

Biography

I am a Clinical Lecturer in Infectious Diseases and Microbiology (Oxford University Hospital NHS Foundation Trust) and Associate Group Leader based primarily at the Wellcome Centre for Human Genetics.

Research interests:

We are a multi-pathogen sequencing lab that has delivered bespoke sequencing methods and large NGS datasets to a  range of studies and consortia including PANGEA, BEEHIVE, HIV Prevention and Trials Network (HPTN), COG-UK, (UK) Office of National Statistics COVID-19 Prevalence Survey and the Oxford Vaccine Group (Oxford, AstraZeneca vaccine).

We develop pathogen-genotyping and sequencing solutions for a range of technology platforms, and have a track-record of developing methods around the question. 

  • Long-read protocols (transmission and long-range haplotyping)
  • Bait enrichment (diverse pathogens)
  • Multi-pathogen bait enrichment (viromes, microbiomes) 
  • Rapid genotyping protocols (diagnostics).
  • High-thoughput, low-cost surveillance (COVID surveillance)
  • Portable, scalable sequencing (AMPHEUS)  

Additionally, we collaborate on a variety of projects to develop, test-simulate and evaluate digital health interventions for infectious diseases

  • Exposure Notification Apps (Contact Tracing Apps)
  • Community Access Diagnostics
  • Public engagement (@OxfordViromics) 

AMPHEUS


AMPHEUS: Analytical Microbiology for Precision Health and Epidemiology – A Unified Solution. AMPHEUS will establish scalable and portable, high-throughput sequencing laboratories in Sub-Saharan Africa. The project is funded by the Bill and Melinda Gates foundation and is a collaboration with Zambart (LSHTM and University of Zambia's School of Medicine). 

PopART Phylogenetics (HPTN 071-2): A Zambian phylogenetic study of HIV transmission and prevention. 

Oxford Viromics: An Oxford University pipeline for sequencing and studying clinically relevant viral pathogens.

Recent publications

Identification and masking of artifactual and misleading within-host variants in deep-sequencing SARS-CoV-2 data

Journal article

Anker KM. et al, (2026), Molecular Biology and Evolution, 43

Patterns of HIV-1 Viral Load Suppression and Drug Resistance During the Dolutegravir Transition: A Population-based Longitudinal Study

Journal article

Martin MA. et al, (2026), Clinical Infectious Diseases, 82, e1242 - e1251

The cumulative incidence and infection hospitalization risk of SARS-CoV-2 by variant: a longitudinal study in England

Journal article

Gaughan C. et al, (2026), American Journal of Epidemiology, 195, 188 - 197

HIV drug resistance during antiretroviral therapy scale-up in Uganda, 2012–19: a population-based, longitudinal study

Journal article

Martin MA. et al, (2025), The Lancet Microbe, 6, 101218 - 101218